Table 3

SNP 6.0 array-based lesion detection (all lesions) and survival in AML (univariate analysis)

SNP 6.0 array genomic lesions or other risk factorsAll-treatment group
Intensive-treatment group
Survival (median, d)Hazard ratioCIPSurvival (median, d)Hazard ratioCIP
0 vs ≥ 1 826/264 1.99 1.19-3.32 < .008 870/338 1.94 1.11-3.39 .02 
≤ 1 vs ≥ 2 795/133 3.83 2.35-6.23 < .001 870/134 3.58 2.1-6.12 < .001 
≤ 2 vs ≥ 3 584/122 3.77 2.31-6.16 < .001 795/122 3.56 2.07-6.14 < .001 
≤ 9 vs ≥ 10 421/122 3.73 2.03-6.86 < .001 472/109 3.76 1.83-7.75 < .001 
5q−/−5 vs not 5q−/−5 128/472 3.62 2.09-6.26 < .001 128/584 3.46 1.85-6.48 < .001 
7q−/−7 vs not 7q−/−7 115/433 2.79 1.62-4.79 < .001 102/530 3.07 1.68-5.62 < .001 
p53 exons 2-9 mutations vs not 104/433 4.16 2.33-7.41 < .001 112/520 4.11 2.12-7.99 < .001 
p53 exons 2-9 mutations or 17p-LOH vs not 122/472 3.84 2.23-6.61 < .001 123/568 3.46 1.85-6.49 < .001 
SNP 6.0 array genomic lesions or other risk factorsAll-treatment group
Intensive-treatment group
Survival (median, d)Hazard ratioCIPSurvival (median, d)Hazard ratioCIP
0 vs ≥ 1 826/264 1.99 1.19-3.32 < .008 870/338 1.94 1.11-3.39 .02 
≤ 1 vs ≥ 2 795/133 3.83 2.35-6.23 < .001 870/134 3.58 2.1-6.12 < .001 
≤ 2 vs ≥ 3 584/122 3.77 2.31-6.16 < .001 795/122 3.56 2.07-6.14 < .001 
≤ 9 vs ≥ 10 421/122 3.73 2.03-6.86 < .001 472/109 3.76 1.83-7.75 < .001 
5q−/−5 vs not 5q−/−5 128/472 3.62 2.09-6.26 < .001 128/584 3.46 1.85-6.48 < .001 
7q−/−7 vs not 7q−/−7 115/433 2.79 1.62-4.79 < .001 102/530 3.07 1.68-5.62 < .001 
p53 exons 2-9 mutations vs not 104/433 4.16 2.33-7.41 < .001 112/520 4.11 2.12-7.99 < .001 
p53 exons 2-9 mutations or 17p-LOH vs not 122/472 3.84 2.23-6.61 < .001 123/568 3.46 1.85-6.49 < .001 
Close Modal

or Create an Account

Close Modal
Close Modal